Cheap Antidepressant Shows Promise Treating Early COVID-19
Interactive Video
•
Other
•
University
•
Hard
Wayground Content
FREE Resource
Fluvoxamine, a drug used for 30 years to treat OCD and depression, may also reduce inflammation and lower the risk of COVID hospitalization. A study involving 1500 COVID patients from Canada, the US, and Brazil showed that those who took fluvoxamine had a 33% reduction in hospitalizations compared to those who received a placebo.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What was the control group given in the study?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What was the percentage reduction in hospitalizations for those who took fluvoxamine?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
